630121-79-8

Basic information

• Product Name: 3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
• Synonyms: 3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester;3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
• CAS NO: 630121-79-8
• Molecular Formula: C₁₅H₂₂N₂O₂
• Molecular Weight: 262.351
• Mol File: 630121-79-8.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester(630121-79-8)
• EPA Substance Registry System: 3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester(630121-79-8)

Safety Data

• Hazardous Substances Data: 630121-79-8(Hazardous Substances Data)

Upstream product

• 98977-36-7 3-oxo-piperidine-1-carboxylic acid tert-butyl ester 
• 149108-74-7 5-trifluoromethanesulfonyloxy-3,4-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 13115-43-0 2-pyridineacetic acid 
• 1658-42-0 methyl 2-pyridylacetate 
• 51551-15-6 3-(pyridin-2-yl)piperidin-2-one 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

Oximes and hydrazones that are useful in treating sexual dysfunction

The present invention relates to oximes and hydrazones of formula (I) for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual dysfunction.

Acetamides and benzamides that are useful in treating sexual dysfunction

The present invention relates to the use of compounds of formula (I) for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual dysfunction.